Table 1.
Registered COVID-19 treatment studies that exclude pregnant women
| Number of COVID-19 treatment studies (April 7–10, 2020) | Number of treatment studies excluding pregnant women (April 7–10, 2020) | Cumulative COVID-19 treatment studies*(July 10–15, 2020) | Cumulative number of treatment studies excluding pregnant women (July 10–15, 2020) | |
|---|---|---|---|---|
| UK ISRCTN registry | 4 | 3 (75%) | 6 | 3 (50%) |
| Brazilian Clinical Trials Registry (ReBec) | 2 | 2 (100%) | 2 | 2 (100%) |
| US ClinicalTrials.gov | 84 | 64 (76%) | 429 | 328 (77%) |
| Clinical Trials Registry - India (CTRI) | 2 | 1 (50%) | 5 | 5 (100%) |
| Australia and New Zealand Clinical Trial Registry (ANZCTR) | 3 | 3 (100%) | 6 | 3 (50%) |
| Chinese Clinical Trial Registry (ChiCTR) | 33 | 30 (91%) | 92 | 68 (74%) |
| EU Clinical Trials Register (EU-CTR) | 19 | 18 (95%) | 34 | 28 (82%) |
| Iranian Registry of Clinical Trials (IRCT) | 5 | 3 (60%) | 143 | 101 (71%) |
| The Netherlands Trial Register | 1 | 0 | 1 | 0 |
| Swiss FOPH Human Research Projects | 2 | 0 | 2 | 1 (50%) |
| Total | 155 | 124 (80%) | 722 | 538 (75%) |
Studies are included irrespective of design.
*
Cumulative search in July, 2020, is inclusive of the studies originally identified during April, 2020.